{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T06:01:44Z","timestamp":1780639304163,"version":"3.54.1"},"reference-count":28,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Hypertrophic cardiomyopathy (HCM) is genetically heterogeneous, involving more than 11 genes. Since HCM genetic testing was covered by Japan\u2019s national health insurance in 2022, variant detection and the need for family-based intervention have increased, although funding is limited to symptomatic patients only. In this study, we evaluated institutional genetic testing outcomes, factors associated with pathogenic variants, and follow-up of at-risk relatives. Methods: We retrospectively analyzed individuals with confirmed or suspected HCM who underwent genetic testing between October 2022 and June 2025. Data regarding molecular results, family history of cardiomyopathy or sudden cardiac death in first-, second-, and third-degree relatives, and cascade screening were collected. Statistical analysis was performed using R version 2025.09.2 + 418. Results: Among 33 probands (median age, 54 years; 51% male), 13 individuals (39%) had pathogenic or likely pathogenic variants (PV or LPV), while six (18%) harbored variants of uncertain significance (VUS), and 14 (43%) yielded negative results. The PV or LPV cohort was significantly younger at the time of testing (median, 34 vs. 59 years; p = 0.008) and had a family history of PV or LPV (77% vs. 20%; p = 0.005). Only three relatives from two PV or LPV probands underwent cascade genetic screening; two tested positive and initiated targeted cardiac surveillance. Conclusions: Despite achieving actionable results, the restricted uptake of cascade screening highlights the need for improved communication and systemic support to facilitate family-based testing and precision medicine.<\/jats:p>","DOI":"10.3390\/jcm15114186","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:36:18Z","timestamp":1780076178000},"page":"4186","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genomic Architecture and Cascade Screening Gaps in Hypertrophic Cardiomyopathy: A Real-World Analysis"],"prefix":"10.3390","volume":"15","author":[{"given":"Kaho","family":"Kato","sequence":"first","affiliation":[{"name":"Division of Genomic and Preventive Medicine, Department of Clinical Genomics, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5753-6266","authenticated-orcid":false,"given":"Aki","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Division of Genomic and Preventive Medicine, Department of Clinical Genomics, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Mariya","sequence":"additional","affiliation":[{"name":"Division of Genomic and Preventive Medicine, Department of Clinical Genomics, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan"},{"name":"Department of Obstetrics and Gynecology, Sapporo Medical University School of Medicine, Sapporo 060-0812, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7815-1464","authenticated-orcid":false,"given":"Hidemichi","family":"Kouzu","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo 060-0812, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9655-3985","authenticated-orcid":false,"given":"Toshiyuki","family":"Yano","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo 060-0812, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Kawaharata","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo 060-0812, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Takasu","sequence":"additional","affiliation":[{"name":"Division of Genomic and Preventive Medicine, Department of Clinical Genomics, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayana","family":"Miura","sequence":"additional","affiliation":[{"name":"Division of Genomic and Preventive Medicine, Department of Clinical Genomics, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Seto","sequence":"additional","affiliation":[{"name":"Division of Genomic and Preventive Medicine, Department of Clinical Genomics, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Suda","sequence":"additional","affiliation":[{"name":"Division of Genomic and Preventive Medicine, Department of Clinical Genomics, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Division of Genomic and Preventive Medicine, Department of Clinical Genomics, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijcard.2023.04.005","article-title":"How common is hypertrophic cardiomyopathy\u2026 really?: Disease prevalence revisited 27 years after CARDIA","volume":"382","author":"Massera","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1253\/circj.CJ-20-0910","article-title":"JCS\/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies","volume":"85","author":"Kitaoka","year":"2021","journal-title":"Circ. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e002460","DOI":"10.1161\/CIRCGEN.119.002460","article-title":"Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes","volume":"12","author":"Ingles","year":"2019","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/gim.2013.44","article-title":"Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy","volume":"15","author":"Ingles","year":"2013","journal-title":"Genet. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/gim.2014.205","article-title":"Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: Expanded panels offer limited additional sensitivity","volume":"17","author":"Alfares","year":"2015","journal-title":"Genet. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCULATIONAHA.123.065987","article-title":"Meta-Analysis of Penetrance and Systematic Review on Transition to Disease in Genetic Hypertrophic Cardiomyopathy","volume":"149","author":"Topriceanu","year":"2024","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1253\/circj.CJ-23-0926","article-title":"JCS\/JCC\/JSPCCS 2024 Guideline on Genetic Testing and Counseling in Cardiovascular Disease","volume":"88","author":"Imai","year":"2024","journal-title":"Circ. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jchf.2013.08.007","article-title":"Sarcomere gene mutations are associated with increased cardiovascular events in left ventricular hypertrophy: Results from multicenter registration in Japan","volume":"1","author":"Fujita","year":"2013","journal-title":"JACC Heart Fail."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.jchf.2024.08.005","article-title":"Association of Multiple Nonhypertrophic Cardiomyopathy-Related Genetic Variants and Outcomes in Patients with Hypertrophic Cardiomyopathy","volume":"12","author":"Hiruma","year":"2024","journal-title":"JACC Heart Fail."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1253\/circj.CJ-11-0876","article-title":"Prevalence and distribution of sarcomeric gene mutations in Japanese patients with familial hypertrophic cardiomyopathy","volume":"76","author":"Otsuka","year":"2012","journal-title":"Circ. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13073-022-01149-0","article-title":"The role of genetic testing in diagnosis and care of inherited cardiac conditions in a specialised multidisciplinary clinic","volume":"14","author":"Stafford","year":"2022","journal-title":"Genome Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wu, R.R., Himmel, T.L., Buchanan, A.H., Powell, K.P., Hauser, E.R., Ginsburg, G.S., Henrich, V.C., and Orlando, L.A. (2014). Quality of family history collection with use of a patient facing family history assessment tool. BMC Fam. Pract., 15.","DOI":"10.1186\/1471-2296-15-31"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s44348-025-00055-4","article-title":"Genetic insights into hypertrophic cardiomyopathy: Pathogenesis, diagnosis, and therapeutic implications","volume":"33","author":"Choi","year":"2025","journal-title":"J. Cardiovasc. Imaging"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic Cardiomyopathy in Adulthood Associated with Low Cardiovascular Mortality with Contemporary Management Strategies","volume":"65","author":"Maron","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.115.017633","article-title":"Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated with Low Cardiovascular Mortality with Contemporary Management Strategies","volume":"133","author":"Maron","year":"2016","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/heartjnl-2011-300368","article-title":"A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy","volume":"98","author":"Ingles","year":"2012","journal-title":"Heart"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1177\/0193945918817039","article-title":"Family Relationships Associated with Communication and Testing for Inherited Cardiac Conditions","volume":"41","author":"Shah","year":"2019","journal-title":"West. J. Nurs. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCGEN.119.002803","article-title":"Long-Term Follow-Up Study on the Uptake of Genetic Counseling and Predictive DNA Testing in Inherited Cardiac Conditions","volume":"13","author":"Smets","year":"2020","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e001896","DOI":"10.1161\/CIRCGEN.117.001896","article-title":"Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy","volume":"11","author":"Schinkel","year":"2018","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s10038-023-01163-z","article-title":"Is legislation to prevent genetic discrimination necessary in Japan? An overview of the current policies and public attitudes","volume":"68","author":"Muto","year":"2023","journal-title":"J. Hum. Genet."},{"key":"ref_24","unstructured":"The General Insurance Association of Japan (2026, January 25). Handling of Genetic Information in General Insurance Underwriting and Payment Practices. Available online: https:\/\/www.sonpo.or.jp\/news\/release\/2022\/2205_01.html."},{"key":"ref_25","unstructured":"The Life Insurance Association of Japan (2026, January 25). Handling of Genetic Information in Life Insurance Underwriting and Payment Practices. Available online: https:\/\/www.seiho.or.jp\/info\/news\/2022\/20220527.html."},{"key":"ref_26","unstructured":"(2026, January 25). Genomic Medicine Promotion Act. Available online: https:\/\/laws.e-gov.go.jp\/law\/505AC1000000057."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e1993","DOI":"10.1002\/jgc4.1993","article-title":"Genetic testing and counseling for hypertrophic cardiomyopathy: An evidence-based practice resource of the National Society of Genetic Counselors","volume":"34","author":"Miller","year":"2025","journal-title":"J. Genet. Couns."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/0118715257283752240325082733","article-title":"Mavacamten: A Review of a Novel Therapeutic Approach for Hypertrophic Cardiomyopathy","volume":"23","author":"Memon","year":"2025","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/11\/4186\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:13:17Z","timestamp":1780636397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/11\/4186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15114186"],"URL":"https:\/\/doi.org\/10.3390\/jcm15114186","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]}}}